ALK completes first part of phase 1 trial with peanut
The trial now progresses into its second part, expected to complete later in 2024. ALK to submit a protocol amendment for Phase 1-2 efficacy trial...
Stay updated with breaking news from Lk Abello. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The trial now progresses into its second part, expected to complete later in 2024. ALK to submit a protocol amendment for Phase 1-2 efficacy trial...
2024 financial calendar for ALK (ALKB:DC / OMX: ALK B / AKBLF): 11 January 2024: Silent period 8 February 2024: Annual report 2023 ...
ALK delivers 11% revenue growth with operating profit up 120% in Q2 (unaudited) ALK’s revenue grew by 11% in Q2 2023, driven...
Revenue up 7%, full-year outlook maintained (unaudited) ALK’s overall results in Q1 2023 were largely as expected, with 7% organic revenue growth in...
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced that Henriette Mersebach will take up the position as Executive Vice President,...